Cobimetinib
id:
cobimetinib-162-12949282
title:
Cobimetinib
text:
Cobimetinib, sold under the brand name Cotellic, is an anti-cancer medication used to treat melanoma and histiocytic neoplasms. Cobimetinib is a MEK inhibitor. Cobimetinib is marketed by Genentech. The most common side effects include diarrhea, rash, nausea, vomiting, pyrexia (fever), photosensitivity reaction, abnormal results for certain liver function tests and abnormal results for an enzyme related to muscle breakdown. Cobimetinib was approved for medical use in the United States in November
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Cobimetinib
date created:
2013-08-12T13:26:49Z
date modified:
2024-08-27T22:25:38Z
main entity:
{"identifier":"Q15708292","url":"https://www.wikidata.org/entity/Q15708292"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/d/d4/Cobimetinib.svg","width":512,"height":379}
fields total:
13
integrity:
16